阿尔茨海默病和血管新生
Anthony H Vagnucci1, William W Li
1Department of Psychiatry, The Cambridge Hospital, Cambridge, MA, USA.
Lancet (London, England)
|February 25, 2003
概括
阿尔茨海默病可能源于大脑内皮细胞产生有毒物质并促进神经元死亡. 抑制这种异常的血管生长 (血管生成) 可能提供新的治疗方法.
科学领域:
- 神经科学是一个神经科学.
- 血管生物学 血管生物学
- 病理学 病理学 病理学
背景情况:
- 阿尔茨海默病 (AD) 的病理基础在很大程度上仍未知.
- 目前的假设包括大脑低流,炎症,遗传因素和分子大脑病变.
- 大脑内皮在阿尔茨海默氏病变发生过程中的中心作用尚未得到充分探索.
研究的目的:
- 提出一种假设,血管内皮细胞在阿尔茨海默病中发挥着关键作用.
- 这表明大脑中的异常血管生成有助于AD中神经元的破坏.
- 探索抗血管性疗法在阿尔茨海默病预防和治疗方面的潜力.
主要方法:
- 对有关阿尔茨海默病机制的现有文献的审查.
- 对药物使用和AD发病率的流行病学数据的分析.
- 根据大脑内皮和血管生成的拟议作用,提出一个假设.
主要成果:
- 该假设认为,AD中的大脑内皮细胞分泌粉样蛋白前体基质和神经毒性.
- 由于缺氧和炎症导致的血管生成所驱动的激活的内皮细胞参与其中.
- 流行病学研究表明,某些药物 (NSAIDs,他类药物,H2阻断剂,通道阻断剂) 可能通过抑制血管生成来预防AD.
结论:
- 阿尔茨海默病可能是一种血管生成依赖的疾病.
- 准异常的大脑内皮细胞并抑制血管生成可能是AD的新治疗策略.
- 需要进一步的实验室和临床研究来验证这一假设.
更多相关视频
相关概念视频
Mechanism of Angiogenesis
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...


